Beta-blocker therapy after myocardial infarction

Beta-blocker therapy after myocardial infarction

Led by Dr Stella Talic and Professor Dion Stub

This research investigated the effectiveness and outcomes of beta-blocker therapy after myocardial infarction (MI), with a focus on all-cause mortality, cardiovascular mortality, and recurrent MI. The work included three complementary studies:

  • State-of-the-Art Review: Synthesised the current evidence on beta-blocker therapy post-MI, including efficacy across different LVEF subgroups and patient populations.
  • Nested Case-Control Study Using the VCOR Registry: Analysed real-world data from the Victorian Cardiac Outcomes Registry, examining associations between beta-blocker use, LVEF, and clinical outcomes in contemporary practice.
  • Umbrella Review: Conducted an overview of systematic reviews and meta-analyses to evaluate the robustness of evidence, stratified by study design, patient subgroups, and risk of bias.

These studies collectively aimed to inform LVEF-stratified, individualised treatment decisions, support guideline refinement, and provide practical recommendations for clinicians.

Outputs